Mitomycin EP Impurity A | CAS 621-79-4 - Request Quote
Mitomycin EP Impurity A
| SZ CAT No: | SZ-M028002 |
| CAS No | 621-79-4 |
| Mol.F. | C9H9NO |
| Mol.Wt. | 147.2 |
| Inv. Status | In Stock |
Chemical Name :
Synonym :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
CHNS Ratio (%) :
Usage Note:
Mitomycin EP Impurity A is chemically (E)-3-Phenylprop-2-enamide (as per EP). It is also known as Cinnamamide (EP). Mitomycin EP Impurity A is supplied with detailed characterization data compliant with regulatory guideline. Mitomycin EP Impurity A can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Mitomycin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 621-79-4
Purchase 621-79-4
Order 621-79-4
Enquire 621-79-4
price of 621-79-4
621-79-4 Supplier
621-79-4 Manufacturer
621-79-4 Exporter
buy high quality Mitomycin EP Impurity A
Purchase Mitomycin EP Impurity A
Mitomycin EP Impurity A suppliers
Mitomycin EP Impurity A manufacturers
Mitomycin EP Impurity A price
Order Mitomycin EP Impurity A
Enquire Mitomycin EP Impurity A
Mitomycin EP Impurity A cost
Mitomycin EP Impurity A Supplier
Mitomycin EP Impurity A Distributor
Mitomycin EP Impurity A for Method Validation
Mitomycin Reference Standard
Mitomycin EP Impurity A for ANDA Filing
Mitomycin EP Impurity A for Forced Degradation Studies
Mitomycin EP Impurity A Identification Standards
Mitomycin EP Impurity A for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.